- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lifecore Biomedical Inc (LFCR)
Lifecore Biomedical Inc stock price live, this page displays NASDAQ LFCR stock exchange data. View the LFCR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Lifecore Biomedical Inc real time stock price chart below.
What Is the Lifecore Biomedical Inc Stock Price Today?
The Lifecore Biomedical Inc stock price today is 8.58.
What Is the Stock Symbol for Lifecore Biomedical Inc?
The stock symbol for Lifecore Biomedical Inc is "LFCR."
What Stock Exchange Does Lifecore Biomedical Inc Trade On?
Lifecore Biomedical Inc is listed and trades on the NASDAQ stock exchange.
Is Lifecore Biomedical Inc a Good Stock to Buy?
Determining whether Lifecore Biomedical Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LFCR quote. (ISIN: US5147661046)
What Is the Lifecore Biomedical Inc Stock Price Today?
The Lifecore Biomedical Inc stock price today is 8.58.
What Is the Stock Symbol for Lifecore Biomedical Inc?
The stock symbol for Lifecore Biomedical Inc is "LFCR."
What Stock Exchange Does Lifecore Biomedical Inc Trade On?
Lifecore Biomedical Inc is listed and trades on the NASDAQ stock exchange.
Is Lifecore Biomedical Inc a Good Stock to Buy?
Determining whether Lifecore Biomedical Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LFCR quote. (ISIN: US5147661046)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.45
8.64
52 wk Range
4.76
8.85
LFCR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.458.64
52 wk Range
4.768.85
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LFCR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
9.25
Upside
+7.81%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Lifecore Biomedical Inc Company Profile
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacture of hyaluronate acid in bulk form; and formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. It also provides product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Lifecore Biomedical Inc Earnings Call Summary for Q1/2026
- Lifecore Biomedical exceeded Q3 2025 forecasts with EPS of -$0.29 vs -$0.32 expected and revenue of $31.1M vs $26.35M anticipated, representing 26% growth from the previous period.
- The company improved its financial position by reducing net loss to $10M and achieving adjusted EBITDA of $3.1M, up from -$1.8M, despite a 2.22% stock decline after hours.
- Management provided guidance for the transition period ending December 2025, projecting revenue between $74-76M and adjusted EBITDA of $12-14M.
- CEO Paul Josephs highlighted the company's focus on top and bottom line growth, with 11 late-stage pipeline programs and significant commercial site transfer opportunities.
- Lifecore expects a 45%/55% revenue split between first and second halves of 2026, with a major customer inflection point anticipated in 2027.
Last Updated: 2025-11-06, 05:24 p/m
Read Full TranscriptCompare LFCR to Peers and Sector
Metrics to compare | LFCR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLFCRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.2x | 1.1x | −0.6x | |
PEG Ratio | 0.02 | −0.39 | 0.00 | |
Price/Book | 240.6x | 3.0x | 2.6x | |
Price / LTM Sales | 2.5x | 4.4x | 3.4x | |
Upside (Analyst Target) | 7.8% | 10.4% | 42.0% | |
Fair Value Upside | Unlock | −7.0% | 5.0% | Unlock |
Analyst Ratings
2 Buy
3 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 9.25
(+7.81% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
-0.29 / -0.32
Revenue / Forecast
31.11M / 26.35M
People Also Watch
FAQ
What Is the Lifecore Biomedical (LFCR) Stock Price Today?
The Lifecore Biomedical stock price today is 8.58
What Stock Exchange Does Lifecore Biomedical Trade On?
Lifecore Biomedical is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Lifecore Biomedical?
The stock symbol for Lifecore Biomedical is "LFCR."
What Is the Lifecore Biomedical Market Cap?
As of today, Lifecore Biomedical market cap is 321.46M.
What Is Lifecore Biomedical's Earnings Per Share (TTM)?
The Lifecore Biomedical EPS (TTM) is -1.27.
When Is the Next Lifecore Biomedical Earnings Date?
Lifecore Biomedical will release its next earnings report on Jan 26, 2026.
From a Technical Analysis Perspective, Is LFCR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Lifecore Biomedical Stock Split?
Lifecore Biomedical has split 0 times.
How Many Employees Does Lifecore Biomedical Have?
Lifecore Biomedical has 406 employees.
What is the current trading status of Lifecore Biomedical (LFCR)?
As of Jan 25, 2026, Lifecore Biomedical (LFCR) is trading at a price of 8.58, with a previous close of 8.59. The stock has fluctuated within a day range of 8.45 to 8.64, while its 52-week range spans from 4.76 to 8.85.
What Is Lifecore Biomedical (LFCR) Price Target According to Analysts?
The average 12-month price target for Lifecore Biomedical is USD9.25, with a high estimate of USD10 and a low estimate of USD8.5. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +7.81% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.